EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 94 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,071 | +13.2% | 138,227 | -2.6% | 0.01% | +12.5% |
| Q1 2023 | $946 | -10.2% | 141,851 | +20.3% | 0.01% | -46.7% |
| Q4 2022 | $1,054 | -99.9% | 117,950 | +0.4% | 0.02% | 0.0% |
| Q3 2022 | $1,156,000 | +141.8% | 117,518 | +95.8% | 0.02% | +150.0% |
| Q2 2022 | $478,000 | – | 60,028 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $12,367,000 | 8.01% |
| Cormorant Asset Management, LP | 3,850,000 | $30,646,000 | 2.32% |
| Novo Holdings A/S | 5,587,207 | $44,474,000 | 2.19% |
| Orbimed Advisors | 14,082,680 | $112,098,000 | 2.03% |
| Opaleye Management Inc. | 451,400 | $3,593,000 | 1.62% |
| DAFNA Capital Management LLC | 695,959 | $5,540,000 | 1.51% |
| EcoR1 Capital, LLC | 2,359,808 | $18,784,000 | 0.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $31,308,000 | 0.65% |
| Resolute Capital Asset Partners LLC | 89,190 | $710,000 | 0.51% |
| HighVista Strategies LLC | 103,462 | $824,000 | 0.50% |